Dergiler / Journal of Urological Surgery / 2019 / Cilt: 6 - Sayı: 2

Long-term Results of Patients with Testicular Tumors Undergoing Testis Sparing Surgery: A Single-center Experience

Testis Koruyucu Cerrahi Uygulanan Testis Tümörlü Hastaların Uzun Dönem Sonuçları: Tek-merkez Deneyimi

Sayfa
93–99
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: TSS may have significant functional and cosmetic benefits without worsening oncologic results in appropriately selected patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To determine the clinicopathologic and oncologic outcomes of testis-sparing surgery (TSS) by evaluating the data of patients who underwent TSS in our clinic.
📊
Temel Bulgular & Veri:Materials and Methods: A total of 24 patients (27 testes) who underwent TSS in the last 16 years were included in the study.
💡
Sonuç & Katkı:Conclusion: TSS may have significant functional and cosmetic benefits without worsening oncologic results in appropriately selected patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: To determine the clinicopathologic and oncologic outcomes of testis-sparing surgery (TSS) by evaluating the data of patients who underwent TSS in our clinic. Materials and Methods: A total of 24 patients (27 testes) who underwent TSS in the last 16 years were included in the study. All the patients presented with a solitary testicular mass or bilateral testicular mass. Preoperative tumor markers were investigated and scrotal ultrasonography was performed in all patients. Surgery was performed with inguinal incision, temporary clamping of the spermatic cord and frozen section analysis (FSA) of the lesion. Intraoperative data, histopathological findings, and recurrence status were analyzed. Results: The mean follow-up period was 96 months. The mean age of the patients was 29.7 (18-66) years. The mean tumor diameter was 11 mm (2-18). TSS was performed bilaterally in 3 patients and unilaterally in 24 patients. According to the final pathology report, 18 (66.7%) of the masses were benign and 9 (33.3%) were malignant. Intraoperative FSA was performed in 17 patients (70.8%). FSA revealed malign histopathology in 6 patients and complementary orchiectomy was performed in 4 of these patients. 14 patients (51.9%) were detected to have positive surgical margins. Two of these patients had seminoma diagnosis and radical orchiectomy was performed due to recurrence on follow-up in these patients. TSS was performed in all patients without any significant intra-postoperative complications. Conclusion: TSS may have significant functional and cosmetic benefits without worsening oncologic results in appropriately selected patients.

Abstract

Amaç: Kliniğimizde testis-koruyucu cerrahi (TKC) uygulanan hastaların verilerini değerlendirerek bu yöntemin klinikopatolojik ve onkolojik sonuçlarını belirlemek. Gereç ve Yöntem: Son 16 yılda TKC uygulanan toplam 24 hasta (27 testis) çalışmaya alındı. Tüm hastaların soliter testisinde kitlesi veya bilateral testiküler kitlesi mevcuttu. Tüm hastalarda preoperatif tümör belirteçleri bakıldı ve skrotal ultrasonografi yapıldı. Cerrahi işlem, inguinal insizyon, spermatik kordun geçici olarak klemplenmesi ve lezyonun frozen kesit analizi (FKA) ile yapıldı. İntraoperatif veriler, histopatolojik bulgular ve nüks durumu analiz edildi. Bulgular: Hastaların ortalama takip süresi 96 aydı. Hastaların yaş ortalaması 29,7 (18-66) idi. Ortalama tümör çapı 11 mm (2-18) idi. TKC, 3 hastada bilateral olarak ve 24 hastada tek taraflı olarak uygulandı. Son patoloji raporuna göre kitlelerin 18’i (%66,7) benign, 9’u (%33,3) malign histopatolojiye sahipti. İntraoperatif FKA, 17 hastada (%70,8) gerçekleştirildi. FKA uygulanan altı hastada malign histopatoloji mevcuttu ve bu hastaların 4’ünde tamamlayıcı orşiektomi yapıldı. Cerrahi sınır, 14 hastada (%51,9) pozitifti. Bu hastaların ikisinde seminom teşhisi mevcuttu ve bu hastalarda takipte nüks nedeniyle radikal orşiektomi yapıldı. TKC, tüm hastalarda anlamlı bir intra-, postoperatif komplikasyon olmaksızın gerçekleştirildi. Sonuç: TKC, uygun hastalarda onkolojik sonuçları kötüleştirmeden önemli fonksiyonel ve kozmetik faydalar sağlayabilir.

🔖

Bu Makaleye Atıf Yap

KIZILAY, F., KALEMCİ, S., ŞİMŞİR, A., ANDABIL, H. J., SARSIK, B., ŞEN, S., ÇAL, Ç., CÜREKLİBATIR, İ. (2019). Long-term Results of Patients with Testicular Tumors Undergoing Testis Sparing Surgery: A Single-center Experience. Journal of Urological Surgery, Cilt: 6 - Sayı: 2, 93–99. https://ajindex.com/articles/196416

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol 2011;60:374-379
  2. Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol 2015;33:623-631
  3. Che M, Tamboli P, Ro JY, Park DS, Ro JS, Amato RJ, Ayala AG. Bilateral testicular germ cell tumors: twenty-year experience at M.D. Anderson Cancer Center. Cancer-Am Cancer Soc 2002;95:1228-1233
  4. Heidenreich A, Hofmann R. Quality-of-life issues in the treatment of testicular cancer. World J Urol 1999;17:230-238
  5. Bojanic N, Bumbasirevic U, Bojanic G, Vukovic I, Milojevic B, Pekmezovic T. Testis sparing surgery for treatment of small testicular lesions: Is it feasible even in germ cell tumors? J Surg Oncol 2017;115:287-290
  6. Giannarini G, Mogorovich A, Bardelli I, Manassero F, Selli C. Testis-sparing surgery for benign and malignant tumors: A critical analysis of the literature. Indian J Urol 2008;24:467-474
  7. Seppelt U. Enukleation eines sukzessiven Zweittumors im Resthoden. Therapiewoche 1982;32:560-563
  8. Richie J. Simultaneous bilateral tumors with unorthodox management. World J Urol 1984;2:74
  9. Horstman WG, Haluszka MM, Burkhard TK. Management of testicular masses incidentally discovered by ultrasound. J Urol 1994;151:1263-1265
  10. Heidenreich A, Bonfig R, Derschum W, von Vietsch H, Wilbert DM. A conservative approach to bilateral testicular germ cell tumors. J Urol 1995;153:10-13
  11. Heidenreich A, Albers P, Krege S. Management of bilateral testicular germ cell tumours–experience of the German testicular cancer study group (GTCSG). European Urology Supplements 2006;5:97
  12. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, European Association of U. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas Urol Esp 2012;36:127-145
  13. Yossepowitch O, Baniel J. Role of organ-sparing surgery in germ cell tumors of the testis. Urology 2004;63:421-427
  14. Steiner H, Holtl L, Maneschg C, Berger AP, Rogatsch H, Bartsch G, Hobisch A. Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results. Urology 2003;62:508-513
  15. Carmignani L, Gadda F, Gazzano G, Nerva F, Mancini M, Ferruti M, Bulfamante G, Bosari S, Coggi G, Rocco F, Colpi GM. High incidence of benign testicular neoplasms diagnosed by